Literature DB >> 11413099

Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia.

M F Dixon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11413099      PMCID： PMC1728347          DOI： 10.1136/gut.49.1.2

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  30 in total

Review 1.  Stem cells in epithelial tissues.

Authors:  J M Slack
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

2.  Preventing cancer by disrupting progression of precancerous lesions.

Authors:  W J Blot
Journal:  J Natl Cancer Inst       Date:  2000-12-06       Impact factor: 13.506

3.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.

Authors:  P Correa; E T Fontham; J C Bravo; L E Bravo; B Ruiz; G Zarama; J L Realpe; G T Malcom; D Li; W D Johnson; R Mera
Journal:  J Natl Cancer Inst       Date:  2000-12-06       Impact factor: 13.506

4.  Fractographic study on the growth and multiplication of the gastric gland of the hamster. The gland division cycle.

Authors:  T Hattori; S Fjuita
Journal:  Cell Tissue Res       Date:  1974       Impact factor: 5.249

5.  Epithelial metaplasia and the second anatomy.

Authors:  J M Slack
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

6.  Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study.

Authors:  S Silva; M I Filipe; A Pinho
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

Review 7.  Genetic and epigenetic alterations in carcinogenesis.

Authors:  T Sugimura; T Ushijima
Journal:  Mutat Res       Date:  2000-04       Impact factor: 2.433

8.  A model for gastric cancer epidemiology.

Authors:  P Correa; W Haenszel; C Cuello; S Tannenbaum; M Archer
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321

9.  Gastric precancerous process in a high risk population: cohort follow-up.

Authors:  P Correa; W Haenszel; C Cuello; D Zavala; E Fontham; G Zarama; S Tannenbaum; T Collazos; B Ruiz
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

10.  Active autoimmune gastritis without total atrophy of the glands.

Authors:  M Stolte; K Baumann; B Bethke; M Ritter; E Lauer; H Eidt
Journal:  Z Gastroenterol       Date:  1992-10       Impact factor: 2.000
View more
  15 in total

1.  Risk of gastric carcinoma in patients with atrophic gastritis and intestinal metaplasia.

Authors:  J Y Kang; C Finlayson; J D Maxwell; P Neild
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

2.  Expression of 1A6 gene and its correlation with intestinal gastric carcinoma.

Authors:  Yi-Qiang Liu; Hong Zhao; Tao Ning; Yang Ke; Ji-You Li
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus.

Authors:  Antonio Rollan; Juan Pablo Arab; M Constanza Camargo; Roberto Candia; Paul Harris; Catterina Ferreccio; Charles S Rabkin; Juan Cristóbal Gana; Pablo Cortés; Rolando Herrero; Luisa Durán; Apolinaria García; Claudio Toledo; Alberto Espino; Nicole Lustig; Alberto Sarfatis; Catalina Figueroa; Javier Torres; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 4.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

5.  Histological risk markers for non-cardia early gastric cancer. Pattern of mucin expression and gastric cancer.

Authors:  Akiko Shiotani; Ken Haruma; Noriya Uedo; Hiroyasu Iishi; Ryu Ishihara; Masaharu Tatsuta; Mitutaka Kumamoto; Yukinori Nakae; Shingo Ishiguro; David Y Graham
Journal:  Virchows Arch       Date:  2006-10-13       Impact factor: 4.064

6.  Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study.

Authors:  Bin Lu; Ming-Tao Chen; Yi-Hong Fan; Yan Liu; Li-Na Meng
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

Review 7.  Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence.

Authors:  Guy-D Eslick
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

Review 8.  Helicobacter pylori eradication for gastric cancer prevention.

Authors:  Ting Kin Cheung; Harry H X Xia; Benjamin C Y Wong
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

9.  Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.

Authors:  E J Kuipers; G F Nelis; E C Klinkenberg-Knol; P Snel; D Goldfain; J J Kolkman; H P M Festen; J Dent; P Zeitoun; N Havu; M Lamm; A Walan
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  Protective effect of ascorbic acid in experimental gastric cancer: reduction of oxidative stress.

Authors:  Claudia P M S Oliveira; Paulo Kassab; Fabio P Lopasso; Heraldo P Souza; Mariano Janiszewski; Francisco R M Laurindo; Kioshi Iriya; Antonio A Laudanna
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.